期刊文献+

全人源肝癌噬菌体单链抗体的筛选及特异性鉴定 被引量:2

Screening of human phage antibodies with single-chain variable fragm ent and identifIication of its specificity to liver cancer cells
下载PDF
导出
摘要 目的对全人源肝癌噬菌体单链抗体库进行鉴定,筛选肝癌抗体,同时对抗体的活性及特异性进行鉴定。方法PCR鉴定阳性重组菌TG1中人肝癌ScFv的插入率。先以人成纤维细胞吸附后再以体外培养的肝癌细胞SMMC7721为抗原对所建抗体库进行3轮“吸附洗脱扩增”的亲和筛选。将筛选后的ScFv进行PCR鉴定及双酶切鉴定;通过ELISA法及FCM鉴定其与人肝癌细胞及正常细胞的结合活性。结果ScFv基因插入率为70%。在亲和筛选过程中,肝癌噬菌体单链抗体得到富集,收获率逐轮得到提高,第3轮为第1轮的214倍。筛选后的ScFv进行PCR鉴定及双酶切鉴定,均可检测到目的基因。ELISA分析结果显示18个克隆与SMMC7721呈阳性反应,阳性率为90%,15个克隆与成纤维细胞有交叉反应。得到3株肝癌单链抗体。ScFv的FCM鉴定表明,以正常胎肝细胞L02为对照,ScFv与肝癌结合比率为41.3%。特异性鉴定表明,其与肝癌细胞结合活性明显高于正常细胞。结论利用噬菌体抗体库技术结合减数筛选得到了肝癌噬菌体单链抗体及其基因,且筛选后的抗体片段与人肝癌细胞有特异性的结合活性。 OBJECTIVE: To identify the human phage a ntibodies with single-chain variable fragment(ScFv), to select the ScFv specifi c to hepatocellular cancer and to detcct the avidity and specificity of the ScFv s. METHODS: The recombinant phages inserted with ScFv were determined by PCR.The recombinant phages were panned by human liver cancer ce ll line of SMMC-7721 after they were counter-selected with human fibroblast ce lls and human embrro liver cells L-02.After 3 rounds of biopanning,the ScFvs we re identified by PCR and enzymes digestion,the specificity of ScFv from the mono clonal bacteria was determined by ELISA and FCM.RESULTS:Th e rate of recombinant bacteria inserted with ScFv was 70%. From the 1st round to the 3th round of the panning,the number of the eluted phages increased 214 tim es.The inserted fragments were detected from the selected ScFvs by PCR and enzym es digestion. Positive reactions to SMMC-7721 were detected by ELISA in 18 clon es.The positive rate was 90%.Cross reactions to fibroblast cells were detected i n 15 clones. Three ScFvs to liver cancer cells were acquired. ScFv can combined 41.3% human liver cancer cell line of SMMC-7721 using normal liver cells as co ntrol by FCM. CONSLUSION:ScFvs to liver cancer cells and i ts genes were acquired by the phage antibody panning assisted by subtraction sel ection.The selected ScFvs has avidity specifically to human liver cancer cells. [
出处 《肿瘤防治杂志》 2005年第6期401-404,共4页 China Journal of Cancer Prevention and Treatment
基金 国家自然科学基金资助项目(30371399)
关键词 噬菌体抗体库 单克隆抗体 单链抗体 肝肿瘤 phage antibody library monoclonal antibody single chain variable fragment liver neoplasms
  • 相关文献

参考文献9

  • 1Szardenings M. Phage display of random peptide libraries: applications, limits, and potential [J]. J Recept Signal Transduct Res, 2003,23(4) :307-349.
  • 2陆东东,张锡然,曹祥荣.原发性肝癌中MDR_1基因表达研究[J].临床肝胆病杂志,2003,19(2):111-112. 被引量:2
  • 3Sblattero D,Bradbury A. Exploiting recombination in single bacteria to make large phage antibody libraries[J]. Nat Biotechnol,2000,18(1) :75-80.
  • 4Zampieri S, Mahler M, Bluthner M, et al. Recombinant anti-P protein autoantibodies isolated from a human autoimmune library: reactivity, specificity and epitope recognition[J]. Cell Mol Life Sci, 2003, 60(3):588-598.
  • 5Stockwin L H, Holmes S. The role of therapeutic antibodies in drug discovery[J]. Biochem Soc Trans, 2003,31 (2): 433 - 436.
  • 6Huston J S, George A J. Engineered antibodies take center stage[J]. Hum Antibodies. 2001,10(3- 4): 127- 142.
  • 7Osbourn J, Jermutus L, Duncan A. Current methods for the generation of human antibodies for the treatment of autoimmune diseases[J]. Drug Discov Today, 2003, 8(18) :845-851.
  • 8Korn T, Nettelbeck D M, Volkel T,et al. Recombinant bispecific antibodies for the targeting of adenoviruses to CEA-expressing tumour cells: a comparative analysis of bacterially expressed single-chain diabody and tandem scFv[J]. J Gene Med, 2004,6 (6):642-651.
  • 9Kupsch J M, Tidman N H, Kang N V, et al. Isolation of human tumor-specific antibodies by selection of an antibody phage library on melanoma cells[J]. Clin Cancer Res, 1999,5 (4): 925 -931.

二级参考文献2

  • 1尤汉宁 陈强 蒋和平 等.P-糖蛋白表达对胃癌预后的影响[J].新消化病学杂志,1997,5(6):23-24.
  • 2孙晓东,钟雪云.肿瘤的多药耐药性[J].肿瘤防治研究,1997,24(4):255-259. 被引量:7

共引文献1

同被引文献15

  • 1王炜煜,易继林,邓云华,司进,王从俊,李翔,曹利民.去唾液酸糖蛋白受体特异性单链抗体的优化表达及亲和常数的测定[J].细胞与分子免疫学杂志,2006,22(4):504-506. 被引量:5
  • 2Huston JS,Levinson D,Mudgett-Hunter M,et al.Protein engineering of antibody binding sites:Recovery of specific activity in an anti-digoxin scFv analogue produced inE.coli[J].Proc Natl Acad Sci USA,1988,85(16):5879-5883.
  • 3Horton RM,Hunt HD,Ho SN,et al.Engineering hybrid genes without the use of restriction enzymes:Gene splicing by overlap extension[J].Gene,1989,77(1):61-68.
  • 4Hombach A,Pohl C,Heuser C,et al.Isolation of single chain antibody fragments with specificity for cell surface antigens by phage display utilizing internal image anti-idiotypic antibodies[J].J Immunol Methods,1998,218(1-2):51-61.
  • 5Osbourn J,Jermutus L,Duncan A.Current methods for the generation of human antibodies for the treatment of autoimmune diseases[J].Drug Discov Today,2003,8(18):845-851.
  • 6Szardenings M.Phage display of random peptide libraries:Applications,limits,and potential[J].J Recept Signal Transduct Res,2003,23(4):307-349.
  • 7Rojas G,Almagro JC,Acevedo B,et al.Phage antibody fragments library combining a single human light chain variable region with immune mouse heavy chain variable regions[J].J Biotechnol,2002,94(3):287-298.
  • 8Carter P,Merchant AM.Engineering antibodies for imaging and therapy[J].Curr Opin Biotechnol,1997,8(4):449-454.
  • 9Krauss J, Arndt MA, Martin AC, et al. Specificity grafting of human antibody frameworks selected from a phage display library: generation of a highly stable humanized anti-CD22 single-chain Fv fragment[ J]. Protein Eng, 2003, 16(10) : 753 -759
  • 10Azzazy HM, Highsmith WEJr. Phage display technology:clinical applications and recent innovations[J]. Clin Biochem, 2002, 35(6) : 425 -445

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部